PARP2 and central nervous system cancer: DTX3L is reported to regulate the ubiquitin modification of PARP family proteins (PARP1, PARP2, PARP9, PARP14), promoting proliferation, migration and chemotherapy resistance of lymphoma, glioma, and melanoma (16).